10q “Our October 31, 2018 cash position was not
Post# of 36533
(Total Views: 146)
Posted On: 01/02/2019 10:05:00 PM
10q “Our October 31, 2018 cash position was not sufficient for 12 months of operations. Anticipated revenues associated with the Veneto acquisition are expected to dramatically alter the cash flow landscape.”
I like that phrasing- dramatically alter. Seeing future progress reflected in quarterly reports is what’s important. Gnbt investors didn’t even see 10q’s for awhile until the new CEO personality funded getting Generex’s filings going again. Plus personally securing otes, or however that’s worded, it’s good to see a CEO with so much skin in the game.
I like that phrasing- dramatically alter. Seeing future progress reflected in quarterly reports is what’s important. Gnbt investors didn’t even see 10q’s for awhile until the new CEO personality funded getting Generex’s filings going again. Plus personally securing otes, or however that’s worded, it’s good to see a CEO with so much skin in the game.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼